top of page
tokers-guide-find-the-best-weed-in-dc-lo
NEW 1 to 1 photo editing 122024 (17).png
The head of the U.S. Department of Veterans Affairs (VA) is advocating for expanded access to psychedelics therapy for veterans, emphasizing a desire to "cure" serious mental health conditions. VA Secretary Doug Collins highlighted ongoing clinical trials, including MDMA-assisted therapy, showing promising results. He is collaborating with HHS and FDA to broaden clinical trials and streamline access for veterans. Collins also expressed a commitment to healing veterans rather than simply treating symptoms, despite regulatory hurdles. Congress is also involved, with a House committee approving an amendment for a progress report on a psychedelic therapy pilot program, and bipartisan lawmakers meeting with the VA secretary to discuss pathways for access. There are ongoing legislative efforts and funding initiatives to support psychedelics research and treatment for veterans.

Trump VA Secretary Wants Faster Psychedelics Access for Healing but Notes Regulatory Hurdles

Jul 23, 2025

Source:

Kyle Jaeger

Marijuana Moment

VA Secretary Doug Collins is making waves by championing a shift from simply treating veterans' mental health symptoms to actually curing them using psychedelics. In a recent interview, Collins expressed his strong support for expanding access to substances like MDMA, ibogaine, and DMT, noting that current clinical trials are yielding "really, really good results." While federal regulations still create some red tape, the VA is actively collaborating with the FDA and HHS to streamline these therapies. Even Congress is getting in on the action, with new amendments pushing for progress reports and increased funding for psychedelic research.

This is a massive win for the community because it signals a major move toward mainstream acceptance of plant-based and alternative medicines. For tokers and veterans alike, having high-level officials prioritize "healing" over "maintenance" could eventually pave the way for broader access to natural therapeutic options. It’s a refreshing, pro-cures stance that challenges the old-school pharmaceutical status quo, and we’re here for it.

Recent Reviews

2345
bottom of page